Skip to main content

Table 2 Summarizes the frequencies of comorbidities in terms of median and interquartile range (IQR) recorded for COVID-19 patients by studies included in this review

From: A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?

Comorbidity

Frequency (%)

Studies reported

Median (%)

IQR

Hypertension

28.60

10.8–45.4

8

Cardiovascular diseases

14.60

10.1–21.4

9

Diabetes

13.20

10.2–30.1

12

Cerebrovascular diseases

8.30

2.1–14.3

6

Chronic lung disease

3.20

1.4–15.9

4

Chronic kidney disease

7.20

2.9–20.8

7

Immunocompromised state

4.80

1.1–11.4

6

Chronic liver disease

2.70

1.8–5.0

6

  1. Diabetes was the most frequently recorded comorbidity but hypertension had the highest prevalance amongst patients of the studies that recorded hypertension as a comorbididty. Obesity, underlying endocrine disorders, autoimmune disease, gastrointestinal diseases and obstructive sleep apnea were aslo noted
  2. Chen et al. [73] and Zhang et al. [83] reported presence of cardiovascular and cerebrovascular diseases collectively in 40.4% and 14.3% of their participants respectively
  3. Chen et al. [73] and Zhang et al. [83] also reported presence of underlying chronic gastrointestinal diseases in 11.1% and 9.3%, and underlying endocrine diseases other than diabetes—such as thyroid disorders—in 1.1% and 3.6% of the patients respectively
  4. Richardson et al. [107] and Goyal et al. [108] also reported obesity in 60.6% and 35.8% of their participants
  5. Chen et al. also recorded presence of autoimmune disease in 1.1% of their participants [73]
  6. Obstructive Sleep Apnea (OSA) was noted by Richardson [106], Arentz [109], and Bhatraju [66] as comorbidity amongst 2.7%, 28.8% and 20.8% of their participants respectively